Companies: 10,795·Total market cap: $144.5T
Lantern Pharma Inc.

Lantern Pharma Inc.

LTRNNASDAQHealthcare● Active
$3.75
+$0.16(+4.46%)
Market Cap$47845770
P/E Ratio
52W High$5.744
52W Low$1.11
Overview

Lantern Pharma Inc.(LTRN)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LTRN · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.45ltrn eps ttm · ltrn earnings per shareEarnings history
PE Ratio (TTM)ltrn pe ratio ttm · ltrn price to earningsPE Ratio deep dive
Revenue (TTM)0.00ltrn revenue ttm · ltrn annual revenueFull revenue history
Dividend Yield不分红does ltrn pay dividends · ltrn dividend yieldDividend history
Shares Outstanding10.9Mltrn shares outstanding · ltrn floatShares outstanding history
Next EarningsAug 12, 2026Est.ltrn earnings date · ltrn next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
lantern pharma inc. revenue · ltrn revenue 2025
FY 2025Net Income-$17.1M▲ +17.62% YoY
202320242025
lantern pharma inc. net income · ltrn profit 2025
FY 2025EPS$-1.57▲ +99.92% YoY
202320242025
ltrn eps · lantern pharma inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$15.9MEPS: $-1.45View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy3 位分析师is ltrn a buy · ltrn analyst rating
Strong Buy
0
Buy
2
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$3.75Current
$Avg Target
$High
ltrn price target · ltrn 12 month forecast

合计: 3 · 买入占比: 66.7%

股票表现

完整历史
1D+4.46%
1W+9.01%
1M+78.57%
3M+36.86%
YTD+23.76%
1Y+11.28%
5Y-75.44%

关于 Lantern Pharma Inc.

CEOPanna Sharma
IPO DateJun 11, 2020
Employees24
CountryUS

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensi…

what is lantern pharma inc. · ltrn stock overview · lantern pharma inc. company profile · who is lantern pharma inc. ceo · ltrn NASDAQ · lantern pharma inc. headquarters · lantern pharma inc. business segments

关于股票概览与关键数据

Lantern Pharma Inc.(LTRN)是 Biotechnology 行业的 Healthcare 类公司,于 Jun 11, 2020 在 NASDAQ 上市。截至最近交易日,LTRN 股价为 $3.75,市值约为 $47.8M。过去12个月累计回报 +11.28%,年初至今回报 +23.76%。

根据 3 位华尔街分析师,Lantern Pharma Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 Lantern Pharma Inc. 营收 —,净利润 -$17.1M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Lantern Pharma Inc.(LTRN)股价为 $3.75,在 NASDAQ 上市,52周区间为 $1.11 – $5.74。

LTRN 最新股价LTRN quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议